ENDRA Life Sciences Share Holder Equity 2017-2024 | NDRA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ENDRA Life Sciences share holder equity from 2017 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ENDRA Life Sciences share holder equity from 2017 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$233.2B
Intuitive Surgical (ISRG)	$171.7B
Alcon (ALC)	$47.9B
IQVIA Holdings (IQV)	$43.7B
IDEXX Laboratories (IDXX)	$42.2B
Edwards Lifesciences (EW)	$40.5B
DexCom (DXCM)	$27.6B
STERIS (STE)	$23.8B
SONOVA HOLDING (SONVY)	$21.2B
Waters (WAT)	$19.5B
Hologic (HOLX)	$19B
Sysmex ADR (SSMXY)	$12.6B
Fresenius Medical Care AG KGaA (FMS)	$12.3B
Teleflex (TFX)	$11.4B
Globus Medical (GMED)	$9.4B
Penumbra (PEN)	$7.3B
Glaukos (GKOS)	$6.7B
Masimo (MASI)	$6.1B
TransMedics (TMDX)	$5.2B
Integer Holdings (ITGR)	$4.2B
PROCEPT BioRobotics (PRCT)	$4.1B
Tandem Diabetes Care (TNDM)	$2.8B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.6B
Inari Medical (NARI)	$2.6B
Elekta AB (EKTAY)	$2.5B
Nihon Kohden (NHNKY)	$2.5B
RxSight (RXST)	$2.1B
Integra LifeSciences Holdings (IART)	$1.3B
Pulse Biosciences (PLSE)	$1.2B